Besides, miR-936 was significantly downregulated in NSCLC cells, and its overexpression inactivated the Galphaq Rho GTPase pathway by targeting GPR78, resulting in the repression of cisplatin resistance in NSCLC cells (157). The gene discussed is GNAQ; the disease is non-small cell lung carcinoma.